• OPEN AN ACCOUNT
Indian Indices
Sensex
81,592.45 -318.56
( -0.39%)
Global Indices
Nasdaq
52,349.65 31.56
(0.06%)
Dow Jones
7,578.06 -35.34
(-0.46%)
Hang Seng
61,109.24 289.88
(0.48%)
Nikkei 225
10,906.25 43.16
(0.40%)
Forex
USD-INR
93.92 0.20
(0.22%)
EUR-INR
104.00 -0.26
(-0.25%)
GBP-INR
124.47 -0.25
(-0.20%)
JPY-INR
0.59 0.00
(-0.08%)

EQUITY - MARKET SCREENER

Industry :  
BSE Code
ISIN Demat
Book Value()
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
EPS(TTM)
Face Value()
Div & Yield %
 

strides pharma science ltd
Titan Biotech consolidated net profit rises 66.17% in the March 2026 quarter
Jun 02,2026
Net profit of Titan Biotech rose 66.17% to Rs 6.73 crore in the quarter ended March 2026 as against Rs 4.05 crore during the previous quarter ended March 2025. Sales rose 38.84% to Rs 48.83 crore in the quarter ended March 2026 as against Rs 35.17 crore during the previous quarter ended March 2025.

For the full year,net profit rose 38.83% to Rs 29.89 crore in the year ended March 2026 as against Rs 21.53 crore during the previous year ended March 2025. Sales rose 31.79% to Rs 206.19 crore in the year ended March 2026 as against Rs 156.45 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales48.8335.17 39 206.19156.45 32
OPM %19.8912.99 -18.7216.25 -
PBDT11.585.87 97 43.1028.54 51
PBT10.285.03 104 38.1724.37 57
NP6.734.05 66 29.8921.53 39